The Effect of Device Closure of Patent Foramen Ovale in Elderly Patients With Crytogenic Stoke/TCI "CryptoCard"

Terminated

Phase N/A Results N/A

Summary of Purpose

The primary objective is to evaluate if patent foramen ovale (PFO) closure and antiplatelet medical management can reduce the risk of recurrent stroke or transient ischemic attack (TIA) when compared to antiplatelet medical management alone in elderly patients above 50 years of age with a PFO and a history of cryptogenic... Trial Stopped: Dissatisfactory enrollment rate

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 May 2010.

1 Oct 2009 20 Nov 2009 1 Sep 2011 1 Jun 2015 1 Nov 2009 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available